Cybin CEO Doug Drysdale discusses learnings from psychedelic drug clinical trial missteps, provides examples of the benefits ...

Terns Pharmaceuticals aims to improve upon currently marketed therapies in CML and obesity, using internally discovered small ...

Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions ...

A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far, and what's likely to come in the year ahead.

Imagine a gem hunter facing a vast and uncharted landscape to uncover a single beautiful diamond. It is a bit like drug ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or two days. Customers now expect their healthcare experience to be similarly ...

Life sciences companies face challenges transitioning from R&D to clinical trials due to outdated, fragmented technology systems that struggle to support the complexity of later trial phases.

This webinar explores the transformative potential of AI and ML in clinical data management, highlighting how these technologies can enhance the efficiency and effectiveness of clinical trials. The ...

It’s not as much of a stretch as you might think. I’ve always loved bikes. In my early 20s, I was a competitive athlete in triathlons, which only amplified my interest. As fate would have it, when ...